News: Xenoport Inc (XNPT.OQ)
XNPT.OQ on NASDAQ Stock Exchange Global Select Market
5.36USD
2:08pm EDT
5.36USD
2:08pm EDT
Price Change (% chg)
$-0.06 (-1.11%)
$-0.06 (-1.11%)
Prev Close
$5.42
$5.42
Open
$5.40
$5.40
Day's High
$5.45
$5.45
Day's Low
$5.36
$5.36
Volume
24,027
24,027
Avg. Vol
150,680
150,680
52-wk High
$12.98
$12.98
52-wk Low
$4.62
$4.62
Select another date:
Mon, May 20 2013
XenoPort to drop multiple sclerosis drug, shares fall
- XenoPort Inc said it would stop development of an experimental multiple sclerosis treatment it planned to launch in 2015 after a late-stage trial failed to show significant improvement over a placebo.
UPDATE 2-XenoPort to drop multiple sclerosis drug after trial failure
* Drug does not show statistical significance compared with placebo
XenoPort to drop multiple sclerosis drug after trial failure
May 20 - XenoPort Inc said it will stop developing its experimental multiple sclerosis treatment after data from a late-stage trial showed the drug did not improve patients' condition significantly compared with a placebo.
Select another date:
- Alkermes Adds Multiple Sclerosis Pill To Expanding Pipeline
- 3 Biotech Stocks Under $10 Spiking Higher
- XenoPort's CEO Presents at Special Conference (Transcript)
- XenoPort's CEO Discusses Q1 2013 Results - Earnings Call Transcript
- XenoPort: A High Probablity Run-Up Trade
- A Number Of Actionable Events For XenoPort, With Capital To Back Up The Company
Press Releases
- XenoPort Announces New Employment Inducement Award
- XenoPort to Present at the 24th Annual Piper Jaffray Health Care Conference
- XenoPort and GlaxoSmithKline Mutually Agree to Terminate Their Collaboration on Horizant
- XenoPort Announces New Employment Inducement Award
- XenoPort to Present at the Credit Suisse Healthcare Conference
- XenoPort Reports Third Quarter Financial Results
- XenoPort to Release Third Quarter Financial Results on October 24, 2012
- XenoPort Reports Favorable Metabolism and Pharmacokinetics of XP23829, a Novel Fumaric Acid Ester, in Phase 1 Trial
- XenoPort to Present at the Morgan Stanley Global Healthcare Conference
- XenoPort to Present at the Wedbush Life Sciences Conference

